The effects of single or combined administration of galactooligosaccharide and Pediococcus acidilactici on cutaneous mucus immune parameters, humoral immune responses and immune related genes expression in common carp (Cyprinus carpio) fingerlings
- 2017-11
- Fish & Shellfish Immunology 70
- Maryam Modanloo
- S. Soltanian
- M. akhlaghi
- S. Hoseinifar
- PubMed: 28917489
- DOI: 10.1016/j.fsi.2017.09.032
Abstract
The present study was performed to investigate the effects of single or combined administration of galactooligosaccharide (GOS) and Pediococcus acidilactici on cutaneous mucus immune parameters, humoral immune responses and immune related genes expression in common carp (Cyprinus carpio) fingerlings. Carps were fed experimental diets for 8 weeks as follows: non-supplemented (Control), prebiotic diet (10 g/kg GOS), probiotic diet (1 g/kg [0.9 × 107 CFU] lyophilized P. acidilactici) and synbiotic diet (10 GOS in combination with 1 g/kg [0.9 × 107 CFU] lyophilized P. acidilactici). Unlike skin mucus, the serum lysozyme activity showed no significant difference between carps fed supplemented or control diets, however, remarkable elevation of serum ACH50 activity was noticed in carps fed supplemented diet (pro-, pre- and synbiotic diets) compared control group. Besides, feeding on pro-, pre- and synbiotic supplemented diets significantly increased serum and skin mucus total Ig levels. However, no significant difference was observed between treatments and control group in case of skin mucus proteases activity. There was no significant difference between expression levels of intestinal genes of LYZ and IL1b in fish fed on pre- and synbiotic, compared to the control. However, evaluation of TNF-alpha gene expression in the intestine of carps revealed remarkable down-regulation in treated groups (p < 0.05). These results indicated positive effect of supplementation of carp diet with GOS and P. acidilactici on some mucosal or serum immune parameters.
Keywords: Common carp; Galactooligosaccharide; Gene expression; Mucosal immune parameters; Probiotic; Synbiotic.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Pediococcus acidilactici | Elevated Serum Total Ig Levels | Beneficial | Moderate |
Pediococcus acidilactici | Enhanced Serum ACH50 Activity | Beneficial | Moderate |
Pediococcus acidilactici | Increased Serum Lysozyme Activity | Neutral | Small |
Pediococcus acidilactici | No Change in Skin Mucus Protease Activity | Neutral | Small |
Pediococcus acidilactici | Reduced TNF-Alpha Expression | Beneficial | Large |
Pediococcus acidilactici KABP™-021 | Elevated Serum Total Ig Levels | Beneficial | Moderate |
Pediococcus acidilactici KABP™-021 | Enhanced Serum ACH50 Activity | Beneficial | Moderate |
Pediococcus acidilactici KABP™-021 | Increased Skin Mucus IgG Levels | Beneficial | Moderate |
Pediococcus acidilactici KABP™-021 | Reduced TNF-alpha Gene Expression | Beneficial | Moderate |
Pediococcus acidilactici MAK92P26A | Enhanced Serum ACH50 Activity | Beneficial | Moderate |
Pediococcus acidilactici MAK92P26A | Improved Immune Response | Beneficial | Moderate |
Pediococcus acidilactici MAK92P26A | Reduced TNF-alpha Gene Expression | Beneficial | Moderate |
Pediococcus acidilactici R1001 | Elevated Serum Total Ig Levels | Beneficial | Moderate |
Pediococcus acidilactici R1001 | Enhanced Serum ACH50 Activity | Beneficial | Moderate |
Pediococcus acidilactici R1001 | Increased Serum Lysozyme Activity | Neutral | Small |
Pediococcus acidilactici R1001 | Increased Skin Mucus IgG Levels | Beneficial | Moderate |
Pediococcus acidilactici R1001 | No Change in Skin Mucus Protease Activity | Neutral | Small |
Pediococcus acidilactici R1001 | Reduced Intestinal TNF-alpha Gene Expression | Beneficial | Moderate |
Pediococcus acidilactici VPro29 | Enhanced Serum ACH50 Activity | Beneficial | Moderate |
Pediococcus acidilactici VPro29 | Reduced TNF-alpha Gene Expression in Intestine | Beneficial | Moderate |